Related Articles
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy
The CD79α (HM47/A9) antibody is effective in distinguishing between primary hepatocellular carcinoma and primary intrahepatic cholangiocarcinoma
KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma
Clinicopathologic study on hepatocellular carcinoma negative for hepatitis B surface antigen and antibody to hepatitis C virus.
Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma